Question 1

CLOV vs MRK: which stock scores better overall?

Accepted Answer

Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.7/10 versus Clover Health Investments, Corp (CLOV) at 5.3/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: CLOV or MRK?

Accepted Answer

Clover Health Investments, Corp (CLOV) scores higher on Growth (7.3/10 vs 6.2/10). Clover Health Investments, Corp reports revenue growth (44.7% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is CLOV or MRK more attractively valued?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Value (7.2/10 vs 6.3/10). CLOV trades at 30.1× P/E versus MRK at 11.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about CLOV vs MRK?

Accepted Answer

There are 3 analysts covering CLOV with a consensus price target of $2.82, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: CLOV or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Quality (6.2/10 vs 1.5/10). Net profit margin: CLOV at -4.4%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: CLOV or MRK?

Accepted Answer

Clover Health Investments, Corp (CLOV) scores higher on Financial Health (8/10 vs 7/10). Market beta: CLOV at 2.25, MRK at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of CLOV and MRK?

Accepted Answer

Clover Health Investments, Corp (CLOV) has a market capitalisation of $1.4B, while Merck & Company, Inc. (MRK) has a market cap of $277.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do CLOV or MRK pay dividends?

Accepted Answer

CLOV does not currently pay a dividend, while MRK pays a dividend yield of 3.03%. Dividend yields fluctuate with share price and company payout decisions.

Clover Health Investments, Corp vs Merck & Company, Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals